Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study
Joyce O'Shaughnessy, Susana Sousa, Josefina Cruz, Dame Lesley Fallowfield, Päivi Auvinen, Catarina Pulido, Ana Cvetanovic, Sharon Wilks, Leonor Ribeiro, Mauricio Burotto, Thomas Boulet, Valentine Revelant, Nathalie Theron, Peter Trask, Laurentia Wahyudi, Zuzana Kirchmayer Machackova, Ljiljana Stamatovic